FDA Adverse Event Summary report: N

ACCESS 2I (LXI) IMMUNOASSAY SYSTEM

MDR report key: 1914174 · Received December 3, 2010

Report

Report Number
2122870-2010-00845
Date Received
December 3, 2010
Date of Event
November 3, 2010
Report Date
November 4, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K023049
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLES WERE SERUM AND COLLECTED IN THE ER. THE SAMPLES WERE CENTRIFUGED FOR 5 MINUTES AT 4000 RPM. THE COLLECTION TUBES ARE LOADED AND PROCESSED THROUGH THE CLOSE TUBE ACCESSION. ON (B)(4) 2010, THE CUSTOMER PERFORMED SYSTEM CHECK WHICH MET SPECIFICATIONS. A BCI FIELD SERVICE ENGINEER (FSE) PERFORMED PREVENTIVE MAINTENANCE AND VERIFIED ALL TESTING MET SPECIFICATIONS. FSE DID NOT NOTE ANY HARDWARE ISSUES ASSOCIATED WITH THIS EVENT. A CLEAR ROOT CAUSE CAN NOT BE DETERMINED FRO THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO ERRONEOUS ELEVATED ACCUTNI RESULT ABOVE THE ACUTE MYOCARDIAL INFARCTION (AMI) CUT-OFF FOR ONE PATIENT GENERATED BY THE ACCESS 2I (LXI) IMMUNOASSAY SYSTEM. THE INITIAL SAMPLE AND A SECOND SAMPLE WERE RERUN ON THE SAME UNIT. THE INITIAL SAMPLE RESULT WAS WITHIN THE RISK STRATIFICATION RANGE AND THE SECOND SAMPLE RESULT WAS WITHIN NORMAL REFERENCE RANGE. THE RESULT WAS REPORTED OUT OF THE LABORATORY. UNKNOWN IF PATIENT TREATMENT WAS ADMINISTERED OR WITHHELD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS 2I (LXI) IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. ACCESS2 LXI

Patients

Seq Age Sex Outcome Treatment
1